🇺🇸 FDA
Patent

US 6632807

(2R,4S)-(−)-[N-(4-diethoxyphosphorylmethyl)phenyl]-1,2,4,5- tetrahydro-4-methyl-7,8-methylenedioxy-5-oxo-3-benzothiepin-2-carboxamide

expired A61PA61P19/08

Quick answer

US patent 6632807 ((2R,4S)-(−)-[N-(4-diethoxyphosphorylmethyl)phenyl]-1,2,4,5- tetrahydro-4-methyl-7,8-methylenedioxy-5-oxo-3-benzothiepin-2-carboxamide) held by Takeda Chemical Industries Ltd. expires Mon Oct 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Takeda Chemical Industries Ltd.
Grant date
Tue Oct 14 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61P, A61P19/08